Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Cervical Cancer

  Free Subscription


05.01.2026

1 ACS Omega
1 Acta Med Okayama
2 Acta Obstet Gynecol Scand
1 Actas Esp Psiquiatr
1 Afr J Reprod Health
1 Am J Prev Med
2 Ann Med
1 Anticancer Res
6 Asian Pac J Cancer Prev
1 Biochim Biophys Acta Mol Basis Dis
1 Biomedicines
1 Biomolecules
3 BMC Cancer
3 BMC Health Serv Res
6 BMC Womens Health
4 BMJ Open
3 Brachytherapy
1 Bull Cancer
1 Cancer Causes Control
1 Cancer Immunol Immunother
1 Cancer Manag Res
1 Cancer Med
3 Cancers (Basel)
1 Carbohydr Polym
1 Case Rep Womens Health
2 Cell Death Dis
1 Clin Transl Oncol
1 Contemp Oncol (Pozn)
1 Curr Oncol
1 Curr Opin Obstet Gynecol
1 Diagn Cytopathol
1 Diagn Pathol
1 Diagnostics (Basel)
2 Discov Oncol
1 Drug Des Devel Ther
1 Exp Cell Res
1 Expert Rev Mol Med
1 Expert Rev Vaccines
1 Food Chem Toxicol
1 Front Glob Womens Health
1 Front Immunol
3 Front Oncol
1 Front Public Health
1 Gan To Kagaku Ryoho
2 Gene
1 Gigascience
1 Harefuah
1 Health Policy
1 Health Sci Rep
1 Hell J Nucl Med
1 Hum Cell
1 In Silico Pharmacol
1 Indian J Community Med
1 Indian J Med Res
1 Indian J Public Health
1 Infect Agent Cancer
1 Inquiry
2 Int J Adolesc Med Health
1 Int J Environ Res Public Health
4 Int J Gynaecol Obstet
4 Int J Gynecol Cancer
2 Int J Mol Sci
1 J Cancer Res Ther
1 J Cell Mol Med
1 J Clin Exp Hematop
1 J Clin Med
1 J Clin Transl Sci
1 J Fluoresc
2 J Infect Dis
1 J Obstet Gynaecol India
2 J Obstet Gynaecol Res
1 J Pain Symptom Manage
1 J Prim Care Community Health
1 J Racial Ethn Health Disparities
1 JAMA
1 JCO Glob Oncol
1 Jpn J Radiol
1 Med Oncol
1 Medicina (Kaunas)
1 Microbiol Res
1 Molecules
2 Nat Commun
1 NPJ Digit Med
2 Nurs Womens Health
2 Obstet Gynecol Surv
1 Oncol Res
2 Pak J Med Sci
1 Pathol Res Pract
1 PeerJ
5 Photodiagnosis Photodyn Ther
1 PLoS One
1 Public Health Rep
1 Reprod Health
1 Rev Salud Publica (Bogota)
1 Sci Data
3 Sci Rep
1 South Asian J Cancer
1 Ultrason Imaging
1 Value Health Reg Issues
1 World J Surg Oncol
1 Zhonghua Fu Chan Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    ACS Omega

  1. KIRUBA B, Raja Karthikeyan RRR, Anilkumar SR, Sundararajan V, et al
    Implications of Single-Cell RNA Sequencing in Cervical Cancer: Unravelling the Molecular Landscape.
    ACS Omega. 2025;10:60080-60093.
    PubMed         Abstract available


    Acta Med Okayama

  2. ASANO Y, Nishihara C, Kitayama T, Okawa N, et al
    MRI Images of a Case of Adenocarcinoma, Human Papillomavirus-Independent, Mesonephric Type, of the Uterine Cervix.
    Acta Med Okayama. 2025;79:463-468.
    PubMed         Abstract available


    Acta Obstet Gynecol Scand

  3. EBNER C, Purtscheller R, Feroz B, Rieker J, et al
    Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study.
    Acta Obstet Gynecol Scand. 2025 Dec 21. doi: 10.1111/aogs.70106.
    PubMed         Abstract available

  4. KNUDSEN AS, Randrup TH, Kesmodel US, Booth BB, et al
    Negative margins and negative HPV tests after large loop excision of the transformation zone: A nationwide historical cohort study.
    Acta Obstet Gynecol Scand. 2026;105:186-194.
    PubMed         Abstract available


    Actas Esp Psiquiatr

  5. HE Q, Xiao L, Lan Y, Yao D, et al
    Analysis of the Development Trajectory and Influencing Factors of Depression in Patients With Cervical Cancer During Concurrent Chemoradiotherapy.
    Actas Esp Psiquiatr. 2025;53:1366-1374.
    PubMed         Abstract available


    Afr J Reprod Health

  6. MANGA SM, Lee GM, Ekoue N, Simeni MH, et al
    Prevalence of human papillomavirus and cervical neoplasia among women who have sex with women in Cameroon: A descriptive study.
    Afr J Reprod Health. 2025;29:122-130.
    PubMed         Abstract available


    Am J Prev Med

  7. HOLDERNESS H, Kaufmann J, Erroba J, Marino M, et al
    Changes in breast and cervical cancer screening rates among Latinas after Medicaid expansion.
    Am J Prev Med. 2025 Dec 24:108241. doi: 10.1016/j.amepre.2025.108241.
    PubMed         Abstract available


    Ann Med

  8. WANG F, Wang L, Bai Y
    Research progress of ferroptosis in cervical cancer treatment.
    Ann Med. 2026;58:2611208.
    PubMed         Abstract available

  9. YAN Q, Zhang Z, Li R, Xue J, et al
    Clinical and nutritional-inflammatory biomarkers-based nomogram predicts survival in recurrent or metastatic cervical cancer treated with immune checkpoint inhibitors.
    Ann Med. 2026;58:2603780.
    PubMed         Abstract available


    Anticancer Res

  10. HOSHINO N, Yoshida K, Kanemitsu Y, Toyama A, et al
    Individualized Estimated Glomerular Filtration Rate-based Renal Function Association With Cisplatin Treatment Completion in Cervical Cancer.
    Anticancer Res. 2026;46:273-281.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  11. RAO S, R S, Sarma D, Nath AG, et al
    HPV Screening in Women Living with HIV (WLHIV) in Karnataka, India: Can it be Integrated into ART Centres?
    Asian Pac J Cancer Prev. 2025;26:4513-4523.
    PubMed         Abstract available

  12. BOMUANG K, Saengkhiao M, Chaimay B, Woradet S, et al
    Health Literacy and Factors Associated with HPV Vaccination among Adolescent Students: A Cross-Sectional Analytic Study.
    Asian Pac J Cancer Prev. 2025;26:4387-4396.
    PubMed         Abstract available

  13. SINGH N, Mangal S, Tanwar P, Singhal S, et al
    Evaluating The Feasibility and Acceptability of Cervical Cancer Screening in an Urban Slum Community by HPV Self-Sampling With the Aid of Telecounselling: Lessons Learnt.
    Asian Pac J Cancer Prev. 2025;26:4331-4338.
    PubMed         Abstract available

  14. LEE HY, Chipalo E, Luo Y, Chou C, et al
    Determinants of Female Cancer Screening Awareness in Alabama's Black Belt Region.
    Asian Pac J Cancer Prev. 2025;26:4313-4322.
    PubMed         Abstract available

  15. K C BHANDARI A, Htay ZW, Parvin R, Murakami M, et al
    Prevalence of Cervical Cancer Screening in Asia: A Systematic Review and Meta-Analysis.
    Asian Pac J Cancer Prev. 2025;26:4269-4281.
    PubMed         Abstract available

  16. KRYLYSHKIN M, Chernyakov A, Dil O, Truschuk J, et al
    Radical Trachelectomy Using A Titanium-Nickelide Metal Tricotage Implant to Preserve Fertility in Cervical Cancer Patients.
    Asian Pac J Cancer Prev. 2025;26:4265-4268.
    PubMed         Abstract available


    Biochim Biophys Acta Mol Basis Dis

  17. SHI Y, Zhang Z, Di X, Shen G, et al
    Integrative analysis of single-cell and bulk transcriptomes reveals metabolic heterogeneity and identifies PFKP as a therapeutic target in cervical cancer.
    Biochim Biophys Acta Mol Basis Dis. 2025 Dec 23:168146.
    PubMed         Abstract available


    Biomedicines

  18. GACUTA E, Lawicki M, Grabowska H, Lawicki P, et al
    Role of Matrilysins (MMP-7, MMP-26) and Stromelysins (MMP-3, MMP-10) in Diagnosing Cervical Cancer Patients.
    Biomedicines. 2025;13:2910.
    PubMed         Abstract available


    Biomolecules

  19. JIANG Y, Wei Y, Li Z, Huang Z, et al
    Enhancing CD8(+) T Cells Infiltration Through the Protein Arginine Methyltransferase 5 (PRMT5)/CXCL10 Axis Restricts Cervical Cancer Progression.
    Biomolecules. 2025;15:1717.
    PubMed         Abstract available


    BMC Cancer

  20. GAN S, Tang J, Qin S, Ou Q, et al
    Recombinant Listeria expressing the HPV multivalent E6E7 protein has a broader spectrum of anti-tumor effects against cervical cancer.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15476.
    PubMed         Abstract available

  21. HAN X, Di R, Zhang H, Zhou B, et al
    Evaluation indicators for bladder dysfunction in Chinese patients following cervical cancer surgery: a Delphi study based on nursing outcomes classification.
    BMC Cancer. 2025 Dec 26. doi: 10.1186/s12885-025-15344.
    PubMed         Abstract available

  22. KANG Y, Chang L, Lin H, Liu J, et al
    Development and external validation of a machine learning-based prognostic model for small cell neuroendocrine cervical carcinoma: a multi-center study.
    BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15338.
    PubMed         Abstract available


    BMC Health Serv Res

  23. OOMMEN AM, Ashfaq M, Viswanathan V, Singarayar P, et al
    Readiness to transition to HPV self-collection from VIA screening: a mixed methods health systems assessment from Tamil Nadu, India.
    BMC Health Serv Res. 2025;25:1619.
    PubMed         Abstract available

  24. MIDAKSA M, Destaw A, Getachew S, Tamrat D, et al
    Health system challenges in the diagnostic and treatment pathway for patients with suspected cervical cancer: a qualitative study.
    BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13918.
    PubMed        

  25. ZHANG L, Yang Q, Zhu H, Zheng Z, et al
    Cadonilimab plus chemotherapy compared to chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancer in China: a cost-effectiveness analysis.
    BMC Health Serv Res. 2025 Dec 22. doi: 10.1186/s12913-025-13871.
    PubMed        


    BMC Womens Health

  26. CORREA CM, Zeferino LC, Juliato CT, Bahamondes L, et al
    Association of cervical cancer and intrauterine device use: a narrative review.
    BMC Womens Health. 2025 Dec 27. doi: 10.1186/s12905-025-04239.
    PubMed         Abstract available

  27. MANDIWA C, Sanna M, Gao W
    Association between mass media exposure and cervical cancer screening uptake among women aged 30-49 years in four sub-Saharan African countries: a pooled analysis of demographic and health surveys.
    BMC Womens Health. 2025;25:603.
    PubMed         Abstract available

  28. SORMANI J, Moukam A, Wisniak A, Yakam V, et al
    Psychological and sexual impact of human papillomavirus screening in women in Cameroon: a prospective cohort study.
    BMC Womens Health. 2025;25:602.
    PubMed         Abstract available

  29. ZHU L, Wu Z, Shi S, Xue H, et al
    Dysbiosis of vaginal and peritoneal fluid microbiota in patients with cervical lesions.
    BMC Womens Health. 2025;25:631.
    PubMed         Abstract available

  30. FEREDE KG, Bantie B, Abdu AM, Ferede AG, et al
    Prevalence and predictors of cervical lesions among women on ART in the Awi Zone, Northwest Ethiopia: facility-based cross-sectional study.
    BMC Womens Health. 2025;25:622.
    PubMed         Abstract available

  31. ESCOBAR V, Catalan A, Callejas V, Araya R, et al
    Human papillomavirus (HPV) genotypes extended prevalence in the female population from a city in Northern Chile.
    BMC Womens Health. 2025;25:617.
    PubMed         Abstract available


    BMJ Open

  32. PINGAULT O, Moskal A, Bouvard C, Payet C, et al
    Gynaecological follow-up of adolescent and young adult cancer survivors: a comparative cohort study.
    BMJ Open. 2025;15:e108897.
    PubMed         Abstract available

  33. ASARE M, Ebu Enyan NI, Sencherey VL, Lamptey-Mills E, et al
    Culturally adapting and evaluating an evidence-based communication intervention with HPV self-sampling to improve cervical cancer screening among women living with HIV in Ghana: a mixed-methods study.
    BMJ Open. 2025;15:e105852.
    PubMed         Abstract available

  34. OOMMEN AM, Ashfaq M, Tonsing MV, Cherian AG, et al
    Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN).
    BMJ Open. 2025;15:e101599.
    PubMed         Abstract available

  35. ABASCAL MIGUEL L, Gaitan Barrillas R, Johnston JS, Ward V, et al
    HPV vaccine awareness and uptake in rural Indigenous communities in Guatemala: a cross-sectional study.
    BMJ Open. 2025;15:e107602.
    PubMed         Abstract available


    Brachytherapy

  36. PERELMUTER S, Balogun O
    The global need for brachytherapy innovation in cervical cancer.
    Brachytherapy. 2025 Dec 24:S1538-4721(25)00361.
    PubMed        

  37. STRAATHOF R, Pool LI, van Vliet-Perez SM, Kolkman-Deurloo IK, et al
    Clinical factors affecting the therapeutic dose window in cervical cancer brachytherapy: A systematic review and meta-regression.
    Brachytherapy. 2025 Dec 23:S1538-4721(25)00360.
    PubMed         Abstract available

  38. CHOPRA S, Samanta A, Nagar A, Mittal P, et al
    Is single implant and multiple fractions radio-biologically iso-effective for cervical cancer high-dose-rate brachytherapy: Observation from patient cohorts during COVID pandemic.
    Brachytherapy. 2025 Dec 22:S1538-4721(25)00365.
    PubMed         Abstract available


    Bull Cancer

  39. BLETSAS M, Rodrigues M
    [Tisotumab Vedotin - Metastatic or recurrent cervical cancer as second-line therapy].
    Bull Cancer. 2025 Dec 27:S0007-4551(25)00534.
    PubMed        


    Cancer Causes Control

  40. VILLARREAL XP, He R, Valle D, Kioutchoukova IP, et al
    Preferences of High-Risk HPV-Based Cervical Cancer Screening among Transgender Men and Gender Diverse People Assigned Female at Birth: A Cross-Sectional Study at a Single Academic Center.
    Cancer Causes Control. 2025;37:12.
    PubMed         Abstract available


    Cancer Immunol Immunother

  41. HUANG Q, Wang F, Li X, Zou W, et al
    Multi-omics profiling reveals an immunosuppressive plasma cell subset within tertiary lymphoid structures in cervical cancer.
    Cancer Immunol Immunother. 2025;75:26.
    PubMed         Abstract available


    Cancer Manag Res

  42. MKUU RS, Tohme S, Rivero-Mendoza D, Salloum RG, et al
    Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer.
    Cancer Manag Res. 2025;17:3273-3284.
    PubMed         Abstract available


    Cancer Med

  43. REN Y, Li S, Xiang S, Xu J, et al
    A Retrospective Study on the Clinicopathological Characteristics and Prognostic Analysis of Gynecologic Neuroendocrine Carcinoma.
    Cancer Med. 2026;15:e71488.
    PubMed         Abstract available


    Cancers (Basel)

  44. PHIANPISET R, Detwongya C, Phookiaw S, Manopunya M, et al
    Long-Term Oncological Outcomes of Laparoscopic Versus Open Radical Surgery in Early-Stage Cervical Cancer: A Propensity Score-Matched Analysis.
    Cancers (Basel). 2025;17:3960.
    PubMed         Abstract available

  45. SANTOS F, Caramelo FA, Tomaz JMP, Santana MM, et al
    Exosomes as Emerging Non-Invasive Biomarkers of Cervical Cancer: A Systematic Review and Meta-Analysis.
    Cancers (Basel). 2025;17:3945.
    PubMed         Abstract available

  46. SONG Y, Zou K, Zou L
    Treatment of Pelvic Recurrence After Radiotherapy for Cervical Cancer.
    Cancers (Basel). 2025;17:3934.
    PubMed         Abstract available


    Carbohydr Polym

  47. LU X, Feng L, Zhang L, Gu F, et al
    Covalently assembled dual-functional triple-helix lentinan-Au for cervical cancer therapy.
    Carbohydr Polym. 2026;375:124799.
    PubMed         Abstract available


    Case Rep Womens Health

  48. CRABB K, Okwesa J, Yap JKW, Kwong FL, et al
    Challenges in managing cervical cancer in pregnancy: Three case reports.
    Case Rep Womens Health. 2025;48:e00765.
    PubMed         Abstract available


    Cell Death Dis

  49. LI L, Lin D, Ao K, Zhong S, et al
    YTHDF3 suppresses interferon-stimulated gene (ISG)-dependent antitumor immunity and promotes HPV carcinogenesis in cervical cancer.
    Cell Death Dis. 2025 Dec 26. doi: 10.1038/s41419-025-08188.
    PubMed         Abstract available

  50. WANG J, Liu S, Li P, Negrin YP, et al
    Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer.
    Cell Death Dis. 2025;16:920.
    PubMed         Abstract available


    Clin Transl Oncol

  51. WU X, Wang B, Liu L, Chen Z, et al
    Multi-omics analysis reveals that knockdown of IMPA2 induces apoptosis in cervical cancer cells through ROS/MYC/CDK1 signaling.
    Clin Transl Oncol. 2025 Dec 22. doi: 10.1007/s12094-025-04167.
    PubMed         Abstract available


    Contemp Oncol (Pozn)

  52. PACHOLCZAK-MADEJ R, Lisik-Habib M, Madry R, Szarszewska M, et al
    Real-world outcomes of immune checkpoint inhibitor monotherapy in later lines of recurrent/metastatic cervical cancer - evidence from a rescue access program in Poland.
    Contemp Oncol (Pozn). 2025;29:384-392.
    PubMed         Abstract available


    Curr Oncol

  53. ZHU M, Liu J, Wang Y, Lu H, et al
    Prognostic Significance of Complete Blood Count-Derived Inflammatory Biomarkers in Patients with Small Cell Neuroendocrine Carcinoma of the Cervix.
    Curr Oncol. 2025;32:654.
    PubMed         Abstract available


    Curr Opin Obstet Gynecol

  54. FANT C, Tewari K
    Eradicating cervical cancer in the poorest regions of the world.
    Curr Opin Obstet Gynecol. 2026;38:6-13.
    PubMed         Abstract available


    Diagn Cytopathol

  55. TERZIOGLU HG, Aragao A, Barroeta JE
    "Atypical Glandular Cells" on Cervical Cytology: Correlation Between Glandular Cell Component Volume and Histological Follow-Up.
    Diagn Cytopathol. 2026;54:71-77.
    PubMed         Abstract available


    Diagn Pathol

  56. CHEN G, Zhang W, HuYan Y, Yang Y, et al
    Application value of TPAS staining technique for cervical exfoliated cells in cervical cancer screening.
    Diagn Pathol. 2025 Dec 22. doi: 10.1186/s13000-025-01744.
    PubMed         Abstract available


    Diagnostics (Basel)

  57. GISCA T, Matasariu DR, Ursache A, Socolov DG, et al
    Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review.
    Diagnostics (Basel). 2025;15:3231.
    PubMed         Abstract available


    Discov Oncol

  58. ASFAW MS, Kassahun W
    The role of microRNAs on autophagy in cervical cancer: review.
    Discov Oncol. 2025 Dec 31. doi: 10.1007/s12672-025-04284.
    PubMed        

  59. PAKDAMAN K, Esmaeilnia Shirvani A, Pakdaman K, Karim B, et al
    Systematic review and meta analysis of the global incidence and clinicopathological characteristics of liver metastasis in patients with cervical cancer.
    Discov Oncol. 2025 Dec 27. doi: 10.1007/s12672-025-04255.
    PubMed        


    Drug Des Devel Ther

  60. HE G, Huang Y, Zhang X, Yuan L, et al
    Landscape Analysis of Human Papillomavirus (HPV) Prophylactic Vaccine Clinical Trials in China Based on the NMPA Database.
    Drug Des Devel Ther. 2025;19:11245-11257.
    PubMed         Abstract available


    Exp Cell Res

  61. TUERXUN H, Li J, Liu Q, Tursun M, et al
    MICA/B-Driven NK Cell Dysfunction Promotes Cervical Cancer via Toll Signaling.
    Exp Cell Res. 2025 Dec 29:114876. doi: 10.1016/j.yexcr.2025.114876.
    PubMed         Abstract available


    Expert Rev Mol Med

  62. WU X, Wang D, Mao X, Dong B, et al
    Microbiome-Driven Resistance in Cervical Cancer Therapy: From Mechanistic Dissection to Clinical Translation.
    Expert Rev Mol Med. 2025 Dec 29:1-45. doi: 10.1017/erm.2025.10029.
    PubMed        


    Expert Rev Vaccines

  63. BROTHERTON JML, LaMontagne DS, Bloem PJN
    Global status of HPV vaccination two decades in: effective, safe and preventing cancer.
    Expert Rev Vaccines. 2026;25:2609869.
    PubMed         Abstract available


    Food Chem Toxicol

  64. CHEN X, Wang S, Ding B, Nie Y, et al
    Dibutyl phthalate (DBP) induces cervical injury and promotes malignant transformation of cervical epithelial cells.
    Food Chem Toxicol. 2026;208:115885.
    PubMed         Abstract available


    Front Glob Womens Health

  65. AZHARI HA, Chawdhury M, Islam F, Zakaria GA, et al
    Visual inspection with acetic acid and colposcopy: screening of cervical cancer in resource-limited healthcare settings.
    Front Glob Womens Health. 2025;6:1684205.
    PubMed         Abstract available


    Front Immunol

  66. LIU Z, Zhang S, Wang Y, Zong Y, et al
    Development and validation of immunotherapy nomogram for predicting the efficacy and prognosis of recurrent and metastatic cervical cancer.
    Front Immunol. 2025;16:1662605.
    PubMed         Abstract available


    Front Oncol

  67. ZHANG J, Fu C, Du J
    Artificial intelligence-assisted noninvasive preoperative prediction of lymph nodes metastasis in cervical cancer through a clinical-imaging feature combined strategy.
    Front Oncol. 2025;15:1669396.
    PubMed         Abstract available

  68. MONDAL J, Chatterjee R, Kumar Gourisaria M, Sahni M, et al
    Cervical cancer classification using a novel hybrid approach.
    Front Oncol. 2025;15:1703772.
    PubMed         Abstract available

  69. YAN HY, Shen XP, Tao PP, Jin L, et al
    Deep learning models for cervical cancer subtyping using whole slide images.
    Front Oncol. 2025;15:1574639.
    PubMed         Abstract available


    Front Public Health

  70. HUANG C, Qiu Y, Huang X, Tang H, et al
    A digital health intervention: development and validation of a social media nursing program for sexual dysfunction following cervical cancer radical hysterectomy.
    Front Public Health. 2025;13:1720263.
    PubMed         Abstract available


    Gan To Kagaku Ryoho

  71. FUJISAKI M, Matsumoto K
    [Latest Drug Therapies for Cervical Cancer].
    Gan To Kagaku Ryoho. 2025;52:858-863.
    PubMed         Abstract available


    Gene

  72. TANG C, Jin X
    Deubiquitinating enzymes in endometrial cancer and cervical cancer.
    Gene. 2025 Dec 30:149988. doi: 10.1016/j.gene.2025.149988.
    PubMed         Abstract available

  73. PEREIRA D, Almeida AM, Queiroz JA, Sousa F, et al
    Innovative minicircle DNA vector encoding pri-miR-375 silences E6 and E7 oncoproteins in HPV16-positive CaSki cells.
    Gene. 2026;981:149964.
    PubMed         Abstract available


    Gigascience

  74. MOHAMMADI M, Fell C, Morrison D, Bell S, et al
    Cervical whole-slide images dataset for multiclass classification.
    Gigascience. 2025;14:giaf144.
    PubMed         Abstract available


    Harefuah

  75. BEN ZUR T, Gutvirtz G, Meirovitz M, Davidesko S, et al
    [Cervical Conization and the Future Risk for Preterm Labor and Cesarean Delivery].
    Harefuah. 2025;165:627-632.
    PubMed         Abstract available


    Health Policy

  76. TODOROVA I, Panayotova Y, Kotzeva T, Greenley R, et al
    Cervical cancer in Bulgaria since EU accession in 2007: a struggle in the face of political instability.
    Health Policy. 2026;164:105497.
    PubMed         Abstract available


    Health Sci Rep

  77. DEWAN SMR, Proma AY, Khan SA, Meem SS, et al
    Evaluation of the Association of TNF-alpha rs361525 Gene Polymorphism in Bangladeshi Patients With Breast and Cervical Cancer: A Case-Control Study and Meta-Analysis.
    Health Sci Rep. 2025;8:e71653.
    PubMed         Abstract available


    Hell J Nucl Med

  78. PANG D, Zhang S, Yang H, Liang K, et al
    (18)F-FDG PET radiomics for predicting progression-free survival in locally advanced cervical squamous cell carcinoma.
    Hell J Nucl Med. 2025;28:232-245.
    PubMed         Abstract available


    Hum Cell

  79. BERKEL C
    Radiotherapy or chemoradiotherapy might sensitize cervical cancer cells to plasma membrane rupture during necroptosis by upregulating the expression of SIGLEC12, a recently identified membrane-rupturing protein.
    Hum Cell. 2025;39:24.
    PubMed        


    In Silico Pharmacol

  80. SUJAY PS, Balaji R
    GC-MS and in silico analysis reveal astaxanthin, nimbin, and gamma-sitosterol from Nyctanthes arbor-tristis flowers as dual modulators of HPV E6 and p53 in cervical cancer.
    In Silico Pharmacol. 2025;14:9.
    PubMed         Abstract available


    Indian J Community Med

  81. SHAH A, Kotadia B, Padmanaban R, Patel R, et al
    Assessing High-Risk HPV Infection Rates in Females Undergoing Cervical Cancer Screening in Western India Using HPV-DNA Testing.
    Indian J Community Med. 2025;50:933-938.
    PubMed         Abstract available


    Indian J Med Res

  82. SULTANA F, Chatterjee N, Mukherjee D, Kumar Panda C, et al
    Role of miRNAs, miR-135b-5p & miR-21-5p in metastasis of cervical cancer.
    Indian J Med Res. 2025;162:493-503.
    PubMed         Abstract available


    Indian J Public Health

  83. ABRAHAM P
    Human Papillomavirus Vaccination - A Moment of Prevention, a Lifetime of Protection.
    Indian J Public Health. 2025;69:375-376.
    PubMed         Abstract available


    Infect Agent Cancer

  84. TERKIMBI SD, Paul-Chima UO, Mujinya R, Joan C, et al
    Molecular, immunological and oncogenic mechanisms of cervical cancer mediated by HPV/HIV co-infection, clinical implication and management.
    Infect Agent Cancer. 2025 Dec 30. doi: 10.1186/s13027-025-00729.
    PubMed        


    Inquiry

  85. KUMAR P, Ray A, Hora R, Kumari A, et al
    Social Determinants of Human Papillomavirus Vaccine Uptake Among Adolescent Girls in Low-Middle-Income Countries: A Systematic Review & Meta-Analysis.
    Inquiry. 2025;62:469580251399368.
    PubMed         Abstract available


    Int J Adolesc Med Health

  86. DHUSIYA HR, Sethy P, Pati S, Pradhan SK, et al
    How can the uptake of HPV vaccination be increased in school going girls? a qualitative study with multiple stakeholders in Ganjam, Odisha.
    Int J Adolesc Med Health. 2025;37:421-430.
    PubMed         Abstract available

  87. BANNOUR I, Mastouri S, Bannour R, Saoudi R, et al
    HPV vaccination: analysis of acceptability among mothers - a study of 160 cases.
    Int J Adolesc Med Health. 2025;37:389-396.
    PubMed         Abstract available


    Int J Environ Res Public Health

  88. GRIECO V, Fiorito D, Giorgianni G, Irato E, et al
    HPV Vaccine: An Effective but Underutilized Prevention Tool.
    Int J Environ Res Public Health. 2025;22:1844.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  89. IMARENGIAYE EO, Iweka RO, Anya CJ, Nwaogwugwu JC, et al
    Knowledge, acceptance, uptake barriers and missed opportunities of human papillomavirus vaccine among female adolescents in Benin City, Nigeria: A mixed method study.
    Int J Gynaecol Obstet. 2026;172:373-382.
    PubMed         Abstract available

  90. PERALTA J, Rodriguez J, Acosta JA, Nunez M, et al
    Management of invasive cervical carcinoma in three oncology centers in Latin America: A historical cohort study.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70371.
    PubMed         Abstract available

  91. KARATAS E, Salman MC, Basaran D, Akgor U, et al
    Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70377.
    PubMed         Abstract available

  92. LI M, Xu S, Yang Q, Zheng Z, et al
    Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
    Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
    PubMed         Abstract available


    Int J Gynecol Cancer

  93. MATSUO K, Matsuzaki S, Roman LD
    Response to "Correspondence on 'Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer' by Matsuo et al" by Hu Y and Fang Q.
    Int J Gynecol Cancer. 2025 Dec 5:102840. doi: 10.1016/j.ijgc.2025.102840.
    PubMed        

  94. XU Q, Han J
    Correspondence on "Diagnostic performance of ultrasound-guided biopsy for detecting recurrent or persistent cervical cancer after chemoradiotherapy: a prospective, single-center study" by Mascilini et al.
    Int J Gynecol Cancer. 2025 Dec 5:102846. doi: 10.1016/j.ijgc.2025.102846.
    PubMed        

  95. SONG Y, Ran G, Zeng R, Chen C, et al
    Global burden and temporal trends of cervical cancer in women aged 60 years and older, 1990-2021: a Global Burden of Disease study.
    Int J Gynecol Cancer. 2025;36:102851.
    PubMed         Abstract available

  96. HU Y, Fang Q
    Correspondence on "Identifying the possible candidate population for adjuvant radiotherapy de-escalation for intermediate-risk cervical cancer" by Matsuo et al.
    Int J Gynecol Cancer. 2025 Nov 26:102831. doi: 10.1016/j.ijgc.2025.102831.
    PubMed        


    Int J Mol Sci

  97. ISMAEL AMEEN S, Masoudi M, Azizi H, Skutella T, et al
    HPV-Driven Immune Evasion in Cervical Cancer: Transcriptomic Identification of Downregulated Hub Genes and Suppressed Leukocyte Migration Pathways.
    Int J Mol Sci. 2025;26:12121.
    PubMed         Abstract available

  98. RODRIGUEZ-NAVA C, Cortes-Sarabia K, Riano-Umbarila L, Becerril-Lujan B, et al
    Generation of a scFv Derived from an IgM-Producing Hybridoma for the Detection of REST Expression in Premalignant Lesions and Invasive Squamous Cell Carcinoma.
    Int J Mol Sci. 2025;26:11946.
    PubMed         Abstract available


    J Cancer Res Ther

  99. SHARMA H, Soni KK, Thakur N, Kumar M, et al
    Intracavitary brachytherapy challenge in cervical cancer with a large cervical fibroid: A case report.
    J Cancer Res Ther. 2025;21:1431-1434.
    PubMed         Abstract available


    J Cell Mol Med

  100. PAN M, Yi T, Lei P, Mo J, et al
    Identification of Glutathione Synthetase as a Therapeutic Target for Cervical Cancer via Combining Bioinformatics and Experimental Validation.
    J Cell Mol Med. 2025;29:e70968.
    PubMed         Abstract available


    J Clin Exp Hematop

  101. IKEMOTO A, Uchiyama T, Takeda M, Nakamine H, et al
    Spindle-cell variant of diffuse large B-cell lymphoma in the uterine cervix: a case report and literature review.
    J Clin Exp Hematop. 2025;65:312-317.
    PubMed         Abstract available


    J Clin Med

  102. OPLAWSKI M, Mawlichanow K, Golec-Cera A, Jedrzejczyk A, et al
    Outcomes of Cervical Cancer Treatment Using Total Mesometrial Resection (TMMR) Performed with the Robotic System-A Preliminary Report.
    J Clin Med. 2025;14:8667.
    PubMed         Abstract available


    J Clin Transl Sci

  103. BABU MS, Kasting ML, Rodriguez NM
    Patient attitudes toward HPV self-sampling and community health worker-delivered cervical cancer screening services in an underserved area.
    J Clin Transl Sci. 2025;9:e270.
    PubMed         Abstract available


    J Fluoresc

  104. CHEN M, Guo J, Xu B
    Targeted Fluorescent Polysaccharide Platform for Solute Carrier Protein PCNA Detection and Cervical Squamous Cell Carcinoma Inhibition.
    J Fluoresc. 2025;35:11539-11552.
    PubMed         Abstract available


    J Infect Dis

  105. SIERRA MS, Coto C, Porras C, Herrero R, et al
    Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories.
    J Infect Dis. 2025;232:e906-e915.
    PubMed         Abstract available

  106. HETLAND FALKENTHAL TE, Nygard S, Nygard M
    Beyond Women's Health: Long-Term HPV-related Cancer Trends in Norway.
    J Infect Dis. 2025 Jul 9:jiaf351. doi: 10.1093.
    PubMed         Abstract available


    J Obstet Gynaecol India

  107. RAJI PS, Thomas A, Thomas DS, Thomas V, et al
    Compliance to Standards of Colposcopy in an Effort to Reduce the Cervical Cancer Burden: An Audit.
    J Obstet Gynaecol India. 2025;75:461-466.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  108. HIRAKAWA A, Iwai N, Yanai A, Matsukawa K, et al
    Efficacy of Sentinel Lymph Node Sampling for Early Cervical Cancer: A Single Institute Study.
    J Obstet Gynaecol Res. 2026;52:e70144.
    PubMed         Abstract available

  109. OZBAS S, Gerey S, Koc SO
    Attitudes Towards Early Diagnosis of Cervical Cancer Among Women Applying to a Health Institution in Turkey.
    J Obstet Gynaecol Res. 2025;51:e70174.
    PubMed         Abstract available


    J Pain Symptom Manage

  110. SHI A, Yerebake M, Du Z, Li L, et al
    Acupuncture as adjunctive therapy for cervical cancer pain: a systematic review and meta-analysis.
    J Pain Symptom Manage. 2025 Dec 31:S0885-3924(25)01021.
    PubMed         Abstract available


    J Prim Care Community Health

  111. NAVA M, Earl J, Patel H, Canizares M, et al
    Cancer Disparities and the Political Economy of Healthcare Access: A County-Level Analysis in a High-Disparity County.
    J Prim Care Community Health. 2025;16:21501319251406402.
    PubMed         Abstract available


    J Racial Ethn Health Disparities

  112. ADEKUNLE TE, Adekunle TB, Thomas S
    Black Women's Perceptions of the Challenges Surrounding Cervical Cancer Screening in the United States.
    J Racial Ethn Health Disparities. 2025 Dec 27. doi: 10.1007/s40615-025-02809.
    PubMed         Abstract available


    JAMA

  113. PANT S
    ACS: New Cervical Cancer Screening Guidelines.
    JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23004.
    PubMed        


    JCO Glob Oncol

  114. YOSHIDA-COURT K, Teka B, Cisneros Napravnik T, Karpinets T, et al
    Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical Cancer.
    JCO Glob Oncol. 2025;11:e2500060.
    PubMed         Abstract available


    Jpn J Radiol

  115. NAKASHIMA T, Matsumoto K, Yoshitake T, Kunitake N, et al
    Impact of high-dose pelvic radiotherapy combined with chemotherapy on local control, symptom relief, and safety in patients with stage IVB cervical cancer (FIGO 2018): a two-center retrospective study.
    Jpn J Radiol. 2025 Dec 24. doi: 10.1007/s11604-025-01923.
    PubMed         Abstract available


    Med Oncol

  116. AKBARI P, Ali HA, Negahi M, Frimayanti N, et al
    Investigation of the effect of encapsulating cisplatin with the active compound silibinin in PLGA polymeric nanoparticles on the HeLa cervical cancer cell line.
    Med Oncol. 2025;43:79.
    PubMed         Abstract available


    Medicina (Kaunas)

  117. KIM MH, Yang J, Song DH, Kim CH, et al
    Expression of Core Hippo Pathway Proteins in Cervical Cancer and Their Association with Clinicopathologic Parameters.
    Medicina (Kaunas). 2025;61:2134.
    PubMed         Abstract available


    Microbiol Res

  118. MONTECILLO JAV, Yoo HJ, Lee YY, Park CM, et al
    Streptococcus vaginalis affects cellular dynamics of cervical cancer cells via oxidative stress-induced activation of endoplasmic reticulum unfolded protein response.
    Microbiol Res. 2025;305:128433.
    PubMed         Abstract available


    Molecules

  119. KIM CA, Shelton N, Samudrala M, Savsani K, et al
    AutoEpiCollect 2.0: A Web-Based Machine Learning Tool for Personalized Peptide Cancer Vaccine Design.
    Molecules. 2025;30:4702.
    PubMed         Abstract available


    Nat Commun

  120. YIN J, Zhang S, Wang S, Li Z, et al
    Age-specific clinical performance of HPV-based vs. cytology-based cervical cancer screening in China.
    Nat Commun. 2025 Dec 27. doi: 10.1038/s41467-025-67215.
    PubMed         Abstract available

  121. ZHANG L, Fan X, Ma J, Zhang J, et al
    Distinct immune cell dynamics associated with immune-related adverse events during combined chemoradiation and immune checkpoint inhibitor therapy.
    Nat Commun. 2025;16:11565.
    PubMed         Abstract available


    NPJ Digit Med

  122. WANG W, Yang G, Liu Y, Wei L, et al
    Author Correction: Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center study.
    NPJ Digit Med. 2025;8:774.
    PubMed        


    Nurs Womens Health

  123. FLANAGAN M, Fantasia HC
    A Multicomponent, Team-Based Quality Improvement Project for Improving Cervical Cancer Screenings in Primary Care.
    Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00204.
    PubMed         Abstract available

  124. KIM SK, Fontenot HB
    The Potential of Human Papillomavirus Self-Collection Testing to Improve Cervical Cancer Screening Among Women Living With HIV.
    Nurs Womens Health. 2025 Dec 23:S1751-4851(25)00211.
    PubMed         Abstract available


    Obstet Gynecol Surv

  125. PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al
    Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European
    Obstet Gynecol Surv. 2025;80:759-761.
    PubMed         Abstract available

  126. DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
    Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.
    Obstet Gynecol Surv. 2025;80:702-704.
    PubMed         Abstract available


    Oncol Res


  127. Retraction: MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
    Oncol Res. 2025;33:4157.
    PubMed         Abstract available


    Pak J Med Sci

  128. CHEN T, Zhen L, Su Y, Yi H, et al
    Nomogram for predicting urinary retention after radical hysterectomy for cervical cancer with comparative analysis of surgical methods.
    Pak J Med Sci. 2025;41:3485-3492.
    PubMed         Abstract available

  129. GONG P, Wang H, Wang Y
    Efficacy of laparoscopic versus open abdominal radical hysterectomy on stress response and urodynamic status in patients with early cervical cancer.
    Pak J Med Sci. 2025;41:3359-3364.
    PubMed         Abstract available


    Pathol Res Pract

  130. LIU T, Zhang L, Li Y, Liao W, et al
    Glutamine metabolites promote the progression of cervical cancer by inducing M2 macrophage polarization.
    Pathol Res Pract. 2025;278:156348.
    PubMed         Abstract available


    PeerJ

  131. ZHOU D, Wang R, Huang L, Yan P, et al
    Real-world efficacy assessment for sintilimab in recurrent or metastatic cervical cancer.
    PeerJ. 2025;13:e20477.
    PubMed         Abstract available


    Photodiagnosis Photodyn Ther

  132. CHEN M, Wu Y, Wang L, Li L, et al
    A non-inferiority study of 5-aminolevulinic acid photodynamic therapy (5-ALA-PDT) for high-grade squamous intraepithelial lesions of the cervix in patients of childbearing age: A non-randomized controlled prospective study.
    Photodiagnosis Photodyn Ther. 2025;56:105280.
    PubMed         Abstract available

  133. CHEN M, Li H, Wang L, Li L, et al
    Comparison of the efficacy of photodynamic therapy alone and photodynamic therapy after laser pretreatment for high-grade cervical intraepithelial lesions in women of childbearing age: a prospective study.
    Photodiagnosis Photodyn Ther. 2025;56:105260.
    PubMed         Abstract available

  134. SUN B, Chen Y, Cao D, Xu Y, et al
    Evaluation of the efficacy of carbon dioxide laser combined with 5-aminolevulinic acid photodynamic therapy in treating high-grade vaginal squamous intraepithelial lesions following hysterectomy.
    Photodiagnosis Photodyn Ther. 2025;56:105256.
    PubMed         Abstract available

  135. WANG X, Chen Y, Xu X, Huang J, et al
    Evaluation of the efficacy of topical photodynamic therapy against cervical HPV infection.
    Photodiagnosis Photodyn Ther. 2025;56:105250.
    PubMed         Abstract available

  136. YUAN S, Zhang M, Zhang C, Su Y, et al
    Effect of topical photodynamic therapy with 5-aminolevulinic acid in the treatment of high-risk cervical low-grade squamous intraepithelial lesions.
    Photodiagnosis Photodyn Ther. 2025;56:105248.
    PubMed         Abstract available


    PLoS One

  137. QIU L, Xie Y, Li Y, Huang J, et al
    Association between serum gamma-Glutamyltransferase and the risk of cervical cancer: Evidence from the national health and nutrition examination survey.
    PLoS One. 2026;21:e0339001.
    PubMed         Abstract available


    Public Health Rep

  138. CHENG E, Stubbs JM, Achat HM
    Self-Collection for HPV-Based Cervical Screening: Knowledge and Attitudes of Australian Health Care Workers in an Area With Low Screening Rates, July-November 2023.
    Public Health Rep. 2026;141:43-50.
    PubMed         Abstract available


    Reprod Health

  139. RUHODE N, Madanhire C, Tumushime MK, Gudukeya S, et al
    Perceptions of integrating cervical cancer screening with HIV and sexual and reproductive health services: results from serial multiple methods studies among health workers and women in Zimbabwe.
    Reprod Health. 2025;22:259.
    PubMed         Abstract available


    Rev Salud Publica (Bogota)

  140. BUSTOS-GUTIERREZ MT, Morales-Casetti ML, Vasquez-Palma OA, Bustos-Gutierrez LR, et al
    [Social determinants of health that influence pap smear and mammography screening in Chilean women].
    Rev Salud Publica (Bogota). 2025;27:114162.
    PubMed         Abstract available


    Sci Data

  141. PEREZ BIANCHI P, Anselmo S, Vasquez Currie M, Medel J, et al
    RIVA: An Image Dataset of Conventional Pap Smear Cytology with Multiple Independent Annotations.
    Sci Data. 2025;12:1991.
    PubMed         Abstract available


    Sci Rep

  142. A AMER A, Altabbaa H, Sh Ramadan M, Abdul-Hafez HA, et al
    A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East.
    Sci Rep. 2025 Dec 29. doi: 10.1038/s41598-025-30866.
    PubMed        

  143. EMON HH, Kowbi RN, Chowdhury MN, Teep TR, et al
    Assessing knowledge, attitudes, and barriers toward HPV cervical cancer and vaccination among female university students in Bangladesh.
    Sci Rep. 2025;15:44529.
    PubMed         Abstract available

  144. CAI L, Luo X, Wu C, Deng X, et al
    Prognostic value of ultrasonography findings in patients with cervical cancer.
    Sci Rep. 2025;15:44471.
    PubMed         Abstract available


    South Asian J Cancer

  145. SHEWALKAR BK, Pant P, Patel J, Patil A, et al
    Neoadjuvant Chemotherapy Followed by Interdigitated Brachytherapy versus Standard Chemoradiation in Locally Advanced Cervical Cancer.
    South Asian J Cancer. 2025;14:404-410.
    PubMed         Abstract available


    Ultrason Imaging

  146. DONG S, Feng YN, Li XY, Peng YQ, et al
    An Ultrasound Radiomics Model for the Early Diagnosis of Cervical Cancer.
    Ultrason Imaging. 2025 Dec 29:1617346251403960. doi: 10.1177/01617346251403960.
    PubMed         Abstract available


    Value Health Reg Issues

  147. SULTANOV M, Pan F, Naheed N, Rahman A, et al
    Costing of Cervical Cancer Screening and Treatment Pathways: Case Studies in Bangladesh and Uganda.
    Value Health Reg Issues. 2025;54:101566.
    PubMed         Abstract available


    World J Surg Oncol

  148. SHAN H, Xu Q
    Prognostic significance of pretreatment systemic immune-inflammation index (SII) in patients with cervical cancer: a meta-analysis.
    World J Surg Oncol. 2025 Dec 23. doi: 10.1186/s12957-025-04167.
    PubMed        


    Zhonghua Fu Chan Ke Za Zhi

  149. ZHANG J, Zhao J, Cui RR, Wang TT, et al
    [Clinical outcomes of people with abnormal cervical cancer screening results but normal colposcopy findings].
    Zhonghua Fu Chan Ke Za Zhi. 2025;60:958-967.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.